Analgesics in Bolivia

Abstract
At the start of the COVID-19 pandemic systemic analgesics, such as acetaminophen and aspirin witnessed a surge in usage as they were recommended by the Bolivian government as effective treatments to support Coronavirus sufferers and also as a palliative against discomfort and the possible effects of receiving the vaccine. With the significant reduction in COVID-19 cases in 2022 and the return to more normal life, analgesics experienced a slight decline in current value sales, although levels rem...

Euromonitor International's Analgesics in Bolivia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Analgesics in Bolivia

List Of Contents And Tables

ANALGESICS IN BOLIVIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Systemic analgesics contracts as demand normalises post-pandemic
The return to the normalisation of physical activities is reflected in the organic growth of topical analgesics
Flogiatrin gaining ground supported by free sampling
PROSPECTS AND OPPORTUNITIES
Analgesics growth to benefit from improved knowledge and access in rural communities
Growing threat from illegal trade of analgesics
Fast-relief systemic analgesics to gain popularity
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN BOLIVIA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources